麻豆蜜桃mv在线观看

麻豆蜜桃mv在线观看
Zoll header_$.png

Nationwide, communities continue to battle the effects of the opioid crisis. Litigation brought by states against drug distributors, manufacturers and pharmacy chains has produced opioid settlement funding designed to bring relief to communities affected by the epidemic. The various funding mechanisms (how to request, how to apply and to who) is evolving and varies by state.

First responders are on the front line of this crisis treating overdose patients, securing illegal, dangerous drugs and managing the various scenarios related to opioid calls. For public safety agencies, including EMS, opioid settlement funding may be tapped for a variety of purposes. For this reason, public safety leaders must understand the basics of the settlements, how funds will be distributed and how your agency may be able to tap into funding in a responsible manner.

Follow our Opioid Settlement Funding: Compensation For Communities coverage, brought to you by ZOLL Medical, to stay informed.

SPONSORED BY
Related news about the opioid crisis and improving patient outcomes
Five options for exchanging the SGA for an endotracheal tube
From vocal cords to alveoli, and mmHg to Lpm: Test your airway knowledge
The state-of-the industry survey focuses on wellness, career development and satisfaction in EMS
Michael Ladell Thomas faces manslaughter, felony DUI for a crash that killed ASAP EMS EMT Mary 鈥淜atie鈥 Pipkin
A surge in fentanyl deaths has become a top legislative issue in both states to
Funding from the U.S. Department of Health and Human Services is to help EMS support residents in rural communities
Portland saw a record number of fatalities in the homeless population due to drug overdoses
The report showed that fentanyl was found in 93% of all opioid-related overdose deaths
13,400 people were killed in DUI crashes in 2021, costing $280 billion in medical expenses, lost wages and loss of quality of life
About the Sponsor: ZOLL
ZOLL is a resuscitation solutions pioneer, distinguished by consistency in management, ownership, and approach for nearly 30 years. As a financially strong, public company, ZOLL has an enviable product quality and reliability record. ZOLL technologies to help advance the practice of resuscitation include pacing, defibrillation, circulation, ventilation, data management, and fluid resuscitation.

These comprehensive technologies help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest and trauma victims. ZOLL鈥檚 commitment is to be the dependable choice for all providers in the field of resuscitation.

ZOLL markets and sells its products, including AED Plus庐, AED Pro庐, the R Series鈩 defibrillator, the AutoPulse庐 non-invasive cardiac support pump, and the LifeVest庐 wearable defibrillator in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.